Pancreatic Cancer Research

ResearcherChinese University of Hong KongNo recent work listed

Sharen Lee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2401-2837; OpenAlex author ID A5018141723. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2022: 3 papers

Papers 3

  1. Lower risks of new-onset acute pancreatitis and pancreatic cancer in sodium glucose cotransporter 2 (SGLT2) inhibitors compared to dipeptidyl peptidase-4 (DPP4… Co-author DOI 10.1016/j.deman.2022.100115↗
  2. Incidence of pancreatic cancer in angiotensin-converting enzyme inhibitors (ACEIs) versus angiotensin receptor blockers (ARBs): a population-based cohort study Co-author DOI 10.1101/2022.07.26.22278092↗
  3. Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study. Last author DOI 10.1210/jendso/bvac138↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gary Tse · 3 shared papers, 2022 · strength 0.42
  2. Bernard M.Y. Cheung · 2 shared papers, 2022 · strength 0.28
  3. Edward Christopher Dee · 2 shared papers, 2022 · strength 0.28
  4. Oscar Hou In Chou · 2 shared papers, 2022 · strength 0.28
  5. Raymond Ngai Chiu Chan · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.